PubRank

T F Murray

Author PubWeight™ 78.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem 2000 1.67
2 A corticosteroid receptor in neuronal membranes. Science 1991 1.66
3 Antillatoxin is a marine cyanobacterial toxin that potently activates voltage-gated sodium channels. Proc Natl Acad Sci U S A 2001 1.20
4 Brevetoxin-induced autocrine excitotoxicity is associated with manifold routes of Ca2+ influx. J Neurochem 2000 1.09
5 Effects of high-intensity resistance training on untrained older men. I. Strength, cardiovascular, and metabolic responses. J Gerontol A Biol Sci Med Sci 2000 1.04
6 Domoic acid neurotoxicity in cultured cerebellar granule neurons is mediated predominantly by NMDA receptors that are activated as a consequence of excitatory amino acid release. J Neurochem 1997 1.01
7 Antillatoxin and kalkitoxin, ichthyotoxins from the tropical cyanobacterium Lyngbya majuscula, induce distinct temporal patterns of NMDA receptor-mediated neurotoxicity. Toxicon 1999 0.97
8 Florida Red Tide: Inhalation Toxicity of Karenia brevis Extract in Rats. Harmful Algae 2002 (2002) 1 0.96
9 The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons. Toxicol Lett 2005 0.95
10 Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes. Proc Natl Acad Sci U S A 1992 0.95
11 Gambierol acts as a functional antagonist of neurotoxin site 5 on voltage-gated sodium channels in cerebellar granule neurons. J Pharmacol Exp Ther 2007 0.95
12 Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence. J Med Chem 1997 0.95
13 Brevetoxins cause acute excitotoxicity in primary cultures of rat cerebellar granule neurons. J Pharmacol Exp Ther 1999 0.95
14 Brevetoxin derivatives act as partial agonists at neurotoxin site 5 on the voltage-gated Na+ channel. Brain Res 2003 0.93
15 PK 11195 antagonism of pyrethroid-induced proconvulsant activity. Eur J Pharmacol 1986 0.93
16 Characterization of glutamate toxicity in cultured rat cerebellar granule neurons at reduced temperature. J Biochem Toxicol 1996 0.92
17 Antillatoxin, a novel lipopeptide, enhances neurite outgrowth in immature cerebrocortical neurons through activation of voltage-gated sodium channels. J Pharmacol Exp Ther 2009 0.92
18 Source of extracellular brain adenosine during hypoxia in fetal sheep. Brain Res 1997 0.92
19 Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors. Neuropharmacology 2005 0.92
20 Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens. Brain Res 1997 0.91
21 Characterization of [3H]MK-801 binding to N-methyl-D-aspartate receptors in cultured rat cerebellar granule neurons and involvement in glutamate-mediated toxicity. J Biochem Toxicol 1996 0.90
22 Partial purification and biochemical characterization of a membrane glucocorticoid receptor from an amphibian brain. J Steroid Biochem Mol Biol 2000 0.90
23 High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Mol Pharmacol 1992 0.89
24 Up-regulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur J Pharmacol 1982 0.89
25 Human skeletal muscle fiber type adaptability to various workloads. J Histochem Cytochem 1984 0.88
26 Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats. Psychopharmacology (Berl) 1998 0.88
27 N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor. Eur J Pharmacol 1997 0.87
28 Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. Life Sci 1984 0.87
29 Theophylline-induced upregulation of A1-adenosine receptors associated with reduced sensitivity to convulsants. Neuropharmacology 1987 0.86
30 Behaviroal, pharmacological, and molecular characterization of an amphibian cannabinoid receptor. J Neurochem 2000 0.85
31 Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium. Eur J Pharmacol 1993 0.85
32 Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist. J Pept Res 2005 0.85
33 Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J Pharmacol Exp Ther 1993 0.85
34 Assessment of skeletal muscle damage in successive biopsies from strength-trained and untrained men and women. Eur J Appl Physiol Occup Physiol 1992 0.84
35 Effect of a 42.2-km footrace and subsequent rest or exercise on muscle glycogen and enzymes. J Appl Physiol Respir Environ Exerc Physiol 1983 0.84
36 Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity. J Med Chem 1992 0.84
37 Synthesis and evaluation of N,N-dialkyl enkephalin-based affinity labels for delta opioid receptors. J Med Chem 2000 0.83
38 Solubilization and pharmacological characterization of a glucocorticoid membrane receptor from an amphibian brain. J Steroid Biochem Mol Biol 1998 0.83
39 Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5-4864 in trout and mouse brain membranes. J Neurochem 1989 0.83
40 A novel acetylated analogue of dynorphin A-(1-11) amide as a kappa-opioid receptor antagonist. J Med Chem 1999 0.83
41 Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells. J Neurochem 1996 0.83
42 Lipid depletion and repletion in skeletal muscle following a marathon. J Neurol Sci 1989 0.82
43 Synthesis and evaluation of potential affinity labels derived from endomorphin-2. J Pept Res 2003 0.82
44 Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat. Neuropharmacology 1985 0.81
45 Possible role for G-proteins in behavioral sensitization to cocaine. Brain Res 1991 0.81
46 Adenosine A1 receptor activation mediates suppression of (-) bicuculline methiodide-induced seizures in rat prepiriform cortex. J Pharmacol Exp Ther 1989 0.81
47 Cyclopentyladenosine-induced homologous down-regulation of A1 adenosine receptors (A1AR) in intact neurons is accompanied by receptor sequestration but not a reduction in A1AR mRNA expression or G protein alpha-subunit content. J Neurochem 1998 0.81
48 Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors. Mol Pharmacol 1988 0.81
49 Stereoselective L-[3H]quinuclidinyl benzilate-binding sites in nervous tissue of Aplysia californica: evidence for muscarinic receptors. J Neurosci 1985 0.80
50 Catecholaminergic CATH.a cells express predominantly delta-opioid receptors. Eur J Pharmacol 1998 0.80
51 Characterization of the preferred stereochemistry for the neuropharmacologic actions of antillatoxin. J Nat Prod 2004 0.80
52 Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors. J Med Chem 2000 0.80
53 High level expression of the NMDAR1 glutamate receptor subunit in electroporated COS cells. J Neurochem 1996 0.80
54 Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor. Mol Pharmacol 1989 0.80
55 N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors. J Med Chem 1992 0.80
56 Dermorphin-based potential affinity labels for mu-opioid receptors. J Pept Res 2003 0.80
57 Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs. J Pharmacol Exp Ther 1982 0.80
58 Muscle fiber composition and blood ammonia levels after intense exercise in humans. J Appl Physiol Respir Environ Exerc Physiol 1983 0.80
59 Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution. J Med Chem 1997 0.79
60 Neuronal location of N6-cyclohexyl[3H]adenosine binding sites in rat and guinea-pig brain. Neuropharmacology 1982 0.79
61 An affinity label for delta-opioid receptors derived from [D-Ala2]deltorphin I. J Pept Res 2004 0.79
62 Levonantradol-induced inhibition of acetylcholine turnover in rat hippocampus and striatum. J Clin Pharmacol 1982 0.79
63 Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands. J Med Chem 2000 0.79
64 Effects of an aerobic exercise program on community-based adults with mental retardation. Ment Retard 1994 0.79
65 Labeling of A1 adenosine receptors in porcine atria with the antagonist radioligand 8-cyclopentyl-1,3-[3H]dipropylxanthine. Eur J Pharmacol 1988 0.79
66 Amino acid neurotransmitter interactions in 'area tempestas': an epileptogenic trigger zone in the deep prepiriform cortex. Epilepsy Res Suppl 1992 0.79
67 Comparison of the binding properties of A1 adenosine receptors in brain membranes of two congeneric marine fishes living at different depths. J Comp Physiol B 1987 0.78
68 Discovery of novel cannabinoid receptor ligands from diverse marine organisms. Adv Exp Med Biol 1997 0.78
69 Regional distribution and characterization of [3H]dextrorphan binding sites in rat brain determined by quantitative autoradiography. J Pharmacol Exp Ther 1996 0.78
70 Activation of adenosine A1 receptors underlies anticonvulsant effect of CGS21680. Eur J Pharmacol 1994 0.78
71 Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence. J Med Chem 1995 0.78
72 Chronic theophylline exposure increases agonist and antagonist binding to A1 adenosine receptors in rat brain. Neuropharmacology 1988 0.78
73 Development of pharmacological sensitivity to adenosine analogs in embryonic chick heart: role of A1 adenosine receptors and adenylyl cyclase inhibition. Mol Pharmacol 1989 0.78
74 Temporal relationship between A1 adenosine receptor upregulation and alterations in bicuculline seizure susceptibility in rats. Neurosci Lett 1989 0.78
75 Cloning and pharmacological characterization of the equine adenosine A3 receptor. J Vet Pharmacol Ther 2006 0.78
76 The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex. Eur J Pharmacol 1993 0.77
77 Pertussis toxin in the A10 region increases dopamine synthesis and metabolism. J Neurochem 1992 0.77
78 [3H]-imipramine binding sites in fawn-hooded rats. Neuropharmacology 1983 0.77
79 Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues. Int J Pept Protein Res 1992 0.77
80 Muscarinic antagonist enhances one-trial food-aversion learning in the mollusc Pleurobranchaea. Brain Res Bull 1988 0.77
81 Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour. Br J Pharmacol 2014 0.77
82 Effects of sodium and temperature on naloxone binding in brain tissues of a urodele amphibian. Comp Biochem Physiol C 1990 0.77
83 Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid. Experientia 1996 0.77
84 Pyrethroid insecticides indirectly inhibit GABA-dependent 36Cl- influx in synaptoneurosomes from the trout brain. Neuropharmacology 1991 0.77
85 Anticonvulsant effect of N-ethylcarboxamidoadenosine against kainic acid-induced behavioral seizures in the rat prepiriform cortex. Neurosci Lett 1990 0.76
86 Involvement of peripheral-type benzodiazepine receptors in the proconvulsant actions of pyrethroid insecticides. J Pharmacol Exp Ther 1988 0.76
87 Cloning and pharmacological characterization of the equine adenosine A2A receptor: a potential therapeutic target for the treatment of equine endotoxemia. J Vet Pharmacol Ther 2006 0.76
88 Identification and initial characterization of high-affinity [3H]dextrorphan binding sites in rat brain. Eur J Pharmacol 1990 0.76
89 The effects of phencyclidine on operant behavior in the rat: biphasic effect and tolerance development. Life Sci 1978 0.76
90 Characterization of [125I]ZM 241385 binding to adenosine A2A receptors in the pineal of sheep brain. Brain Res 2006 0.76
91 Phencyclidine-induced stereotyped behavior in rats: dose response effects and antagonism by neuroleptics. Life Sci 1979 0.76
92 Phylogenetic distribution of [3H]cyclohexyladenosine binding sites in nervous tissue. Biochem Biophys Res Commun 1986 0.76
93 Steroid modulation of GABAA receptors in an amphibian brain. Brain Res 1994 0.75
94 Biosynthesis and cannabinoid receptor affinity of the novel eicosanoid, conjugated triene anandamide. Adv Exp Med Biol 1997 0.75
95 Effects of a Long-Term Fitness Program on Professional Baseball Players. Phys Sportsmed 1989 0.75
96 Effects of monoamine oxidase inhibitors on phencylidine induced stereotyped behavior and brain levels in rats. Proc West Pharmacol Soc 1979 0.75
97 Adenosine receptor activation blocks seizures induced by bicuculline methiodide in the rat prepiriform cortex. Eur J Pharmacol 1988 0.75
98 Arthroscopy of the foot and ankle in the athlete. Clin Sports Med 1996 0.75
99 Characterization of cardiac A1 adenosine receptors with the antagonist radioligand 8-cyclopentyl-1,3[3H]-dipropylxanthine. Proc West Pharmacol Soc 1988 0.75
100 Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid. J Med Chem 1993 0.75
101 Aging: effects on beta-carboline binding in hippocampal subfields. Neurobiol Aging 1984 0.75
102 Dextrorotatory opioids and phencyclidine exert anticonvulsant action in prepiriform cortex. Eur J Pharmacol 1992 0.75
103 Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors. Chirality 2001 0.75
104 Activation of adenosine receptors suppresses behavioral seizures induced by kainic acid in the rat prepiriform cortex. Proc West Pharmacol Soc 1989 0.75
105 Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid. J Med Chem 1993 0.75
106 Interactions between delta9-tetrahydrocannabinol and phencyclidine in rats and mice. Proc West Pharmacol Soc 1976 0.75
107 The effect of phencyclidine on the turnover rate of acetylcholine in various regions of rat brain. J Pharmacol Exp Ther 1981 0.75
108 Pharmacological and behavioral components of tolerance to LSD and mescaline in rats. Pharmacol Biochem Behav 1977 0.75
109 A comparison of the analgesic activities of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) and 6-chloro-2[1-piperazinyl]pyrazine (MK 212). Eur J Pharmacol 1983 0.75
110 Characterization of muscarinic cholinergic receptors in the crab nervous system. J Neurochem 1986 0.75
111 Anemia up-regulates pontine A1 adenosine receptors in fetal sheep. Brain Res 1992 0.75
112 Responses of the isolated buffalo sculpin heart to stabilized venom of the lionfish (Pterois volitans). Proc West Pharmacol Soc 1984 0.75
113 Dependence on gamma-aminobutyric acid of pyrethroid and 4'-chlorodiazepam modulation of the binding of t-[35S]butylbicyclophosphorothionate in piscine brain. Neuropharmacology 1990 0.75
114 Phylogenetic distribution of A1 adenosine receptors in nervous tissue. Proc West Pharmacol Soc 1986 0.75